Home/Filings/4/0001225208-17-004393
4//SEC Filing

BOSTON SCIENTIFIC CORP 4

Accession 0001225208-17-004393

$BSXCIK 0000885725operating

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:24 PM ET

Size

11.3 KB

Accession

0001225208-17-004393

Insider Transaction Report

Form 4
Period: 2017-02-22
Dawkins Keith D
Sr. VP, Chief Medical Officer
Transactions
  • Exercise/Conversion

    Deferred Stock Units

    2017-02-221,7386,952 total
    Exp: 2021-02-22Common Stock (1,738 underlying)
  • Tax Payment

    Common Stock

    2017-02-22$25.16/sh817$20,55676,785 total
  • Exercise/Conversion

    Common Stock

    2017-02-22+1,73877,602 total
Footnotes (2)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000885725

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:24 PM ET
Size
11.3 KB